文献速递关节外科

病态肥胖患者全关节置换术:BMI≥40如何影响患者留存、治疗决策与结局

Total Joint Arthroplasty in the Morbidly Obese: How Body Mass Index ≥40 Influences Patient Retention, Treatment Decisions, and Treatment Outcomes.
PubMed 文献 · J Arthroplasty · 2019-08-17

该回顾性研究分析BMI≥40 kg/m2且髋或膝骨关节炎患者,发现51.3%未复诊,复诊者中42.9%最终手术;手术者初始BMI较低且术前减重显著;BMI≥40组总体并发症不更高,但全髋置换手术部位感染率更高(0.3% vs 3.1%,P<.05);仅9%患者2年随访达到BMI<40。

要点

  • BMI≥40且中度/重度髋膝骨关节炎新患者中51.3%未二次就诊。
  • 复诊患者中42.9%最终接受全关节置换术。
  • 全髋置换中BMI≥40组手术部位感染率3.1%高于BMI<40组0.3%(P<.05)。

核心结论

  • 多数BMI≥40 kg/m2且中度/晚期骨关节炎患者会失访。
  • 相对较低的BMI提示更可能留存于诊疗并最终手术,但不影响医生继续骨科管理的建议。
  • 坚持治疗、显著减重并穷尽非手术方案的患者尽管BMI≥40 kg/m2仍可能适合全关节置换术,总体并发症率为4.3%。
  • 2年随访仅9%患者达到BMI<40 kg/m2,仅20%手术在达到该拟定界值的患者中施行。

研究设计与样本

  • 回顾性研究,纳入158例BMI≥40 kg/m2且髋或膝中度/重度骨关节炎新患者,比较手术与非手术组人口学、合并症和减重。
  • 利用关节置换数据库识别2016-2018年接受全关节置换术的患者1473例,比较BMI≥40与<40 kg/m2组的合并症、再入院、手术部位感染和总体并发症。

主要发现

  • BMI≥40组新患者中51.3%未第二次就诊;复诊者中42.9%最终手术。
  • 单次就诊患者BMI高于多次就诊者(49.5 vs 46.3 kg/m2,P<.001)。
  • 按需预约与指定复诊日期两组无差异(P=.18);2年随访期间BMI无显著变化(P=.41)。
  • 手术患者就诊时平均BMI低于非手术者(44.5 vs 47.6 kg/m2,P<.01),且术前显著减重(44.5 vs 42.6 kg/m2,P<.05)。
  • BMI≥40组总体并发症不高于BMI<40组,但全髋置换中BMI≥40组手术部位感染率更高(0.3% vs 3.1%,P<.05)。

关键数值与推荐

  • 单次就诊患者BMI 49.5 vs 多次就诊者46.3 kg/m2(P<.001)。
  • 手术患者初始BMI 44.5 vs 非手术者47.6 kg/m2(P<.01)。
  • 手术患者术前BMI 44.5 vs 术后42.6 kg/m2(P<.05)。
  • 全髋置换手术部位感染率:BMI≥40组3.1% vs BMI<40组0.3%(P<.05)。
  • 总体并发症率4.3%;2年随访9%患者BMI<40 kg/m2,20%手术患者达到BMI<40 kg/m2。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The United States is in an obesity epidemic. Obesity has multiple common comorbid conditions, including lower extremity arthritis. We sought to examine the course of treatment for a population with body mass index (BMI) ≥40 kg/m2 and osteoarthritis (OA) of the hip or knee. We investigated decision criteria that influenced arthroplasty surgeons to recommend nonoperative management vs total joint arthroplasty (TJA). For those patients who ultimately received TJA, we compared outcomes in this population to those with BMI <40 kg/m2. METHODS: This study retrospectively reviewed 158 new patients with BMI ≥40 kg/m2 and moderate/severe OA of the hip or knee. Demographics, comorbidity profiles, and weight loss were compared between groups that underwent TJA and those that did not. The arthroplasty database was used to identify patients who underwent TJA during 2016-2018 (N = 1473). Comorbidities, readmissions, surgical site infections, and overall complications were compared between those with BMI ≥40 kg/m2 and BMI <40 kg/m2. RESULTS: About 51.3% of new patients with BMI ≥40 kg/m2 and moderate/severe OA did not return for a second clinic visit. Of those who did return, 42.9% eventually underwent surgery. BMI was higher in single visit patients vs those with multiple visits (49.5 vs 46.3 kg/m2, P < .001), no difference in those scheduled on an "as-needed" basis vs a specific return date (P = .18), and did not change significantly during the 2-year follow-up (P = .41). Patients who underwent TJA had a lower mean BMI at presentation than their nonoperative counterparts (44.5 vs 47.6 kg/m2, P < .01) and demonstrated significant weight loss prior to surgery (44.5 vs 42.6 kg/m2, P < .05). When comparing patients with BMI ≥40 kg/m2 vs BMI <40 kg/m2, overall complications were not higher in the BMI ≥40 kg/m2 group, although surgical site infections were higher in those undergoing total hip arthroplasty with BMI ≥40 kg/m2 (0.3% vs 3.1%, P < .05). CONCLUSION: A majority of patients with BMI ≥40 kg/m2 and moderate/advanced OA will be lost to orthopedic follow-up. A relatively lower BMI indicates a greater chance of retention in care, and ultimately surgery, but does not influence surgeons' recommendations to continue orthopedic management. Patients who persist in seeking treatment, lose significant weight, and exhaust nonoperative alternatives may be suitable for TJA despite a BMI ≥40 kg/m2, with an overall complication rate of 4.3%. However, only 9% of patients at 2-year follow-up achieved BMI <40 kg/m2 and only 20% of surgeries were performed on patients who had achieved this proposed cutoff.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Foreman CW, Callaghan JJ, Brown TS, et al. Total Joint Arthroplasty in the Morbidly Obese: How Body Mass Index ≥40 Influences Patient Retention, Treatment Decisions, and Treatment Outcomes. J Arthroplasty. 2019. PMID: 31530460. doi:10.1016/j.arth.2019.08.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。